Hansen-FlaschenJH, BrazinskyS, BasileC, LankenPN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA1991;266:2870–2875.
2.
KlessigHT, GeigerHJ, MurrayMJ, CoursinDB. A national survey on the practice of patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med1992;20:1341–1345.
3.
Hansen-FlaschenJH, CowenJ, RapsEC. Neuromuscular blockade in the intensive care unit: more than we bargained for. Am Rev Respir Dis1993;147:234–236.
4.
SegredoV, CaldwellJE, MatthayMA, SharmaML, GruenkeLD, MillerRD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med1992;327:524–528.
5.
DouglassJA, TuxenDV, HorneM, ScheinkestelCD, WeinmannM, CzarnyD, BowesG.Myopathy in severe asthma. Am Rev Respir Dis1992;146:517–519.
6.
KupferY, NambaT, KaidawiE, TesslerS.Prolonged weakness after long-term infusion of vecuronium. Ann Intern Med1992;117: 484–486.
7.
Op de CoulAWW, LambregtsPCLA, KoemanJ, Van PuyenbroekMJE, TerlaakHJ, Gabreels-FestenAAWM. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during mechanical ventilation. Clin Neurol Neurosurg1980;87:17–22.
8.
GoochJL, SuchytaMR, BalbierzJM, PetajanJH, ClemmerTP. Prolonged paralysis after treatment with neuromuscular blocking drugs. Crit Care Med1991;19:1125–1131.
9.
SheeCD. Risk factors for hydrocortisone myopathy in acute severe asthma. Respir Med1990;84:229–233.
10.
WittNJ, ZochodneDW, BoltonCF, MaisonFG, WellsG, YoungB, SibbaldWH. Peripheral nerve function in sepsis and multiple organ failure. Chest1991;99:176–184.
11.
VandenbromRHG, WierdaMHK. Pancuronium in the intensive care unit: a case of overdose. Anesthesiology1988;69:996–997.
12.
DurbinCG. Neuromuscular blocking agents and sedating drugs: clinical uses and toxic effects in the critical care unit. Crit Care Clin1991;7:489–506.
13.
HiranoM, OttBR, RapsEC, MinettiC, LemnihanL, LibbeyMP, . Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology1992;42:2082–2087.
14.
MillerRD, RuppSM, FisherDM, CronnellyR, FaheyMR, SohnYJ. Clinical pharmacology of vecuronium and atracurium. Anesthesiology1984;61:444–453.
15.
WadonAJ, DograS, AnandS.Atracurium infusion in the intensive care unit. Br J Anaesth1986;58:645–675.
16.
PartridgeBL, AbramsJH, BazemoreC, RubinR.Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med1990;18:1177–1179.
17.
AliHH, SavareseJJ. Monitoring of neuromuscular function. Anesthesiology1976;45(2):216–249.
